|
Form 4 Filings | Insider Buys | Significant Buys |
Penny Stocks Insider Buying |
Insider Sales |
| Insider Buy Sell Ratios | Stock Options |
Insider Trading Top Lists |
Insider Trading Graph View |
Insider Watch |
|
|
"Insiders might sell their shares for any number of reasons, but they buy them for only one:
they think the price will rise" - Peter Lynch ==>> What is insider trading>> |

| Transaction & Date | Reported Date |
Company | Symbol | Insider Relationship |
Shares Traded | Average Price | Total Amount |
Shares Ownership |
Filing |
| 2009-04-02- -2009-10-06 Purchase |
2009-10-21 10:54 am | AEOLUS PHARMACEUTICALS, INC. | AOLS | Cavalier David (Director 10% owner) | 5,932,857 | $0.2808 | $1,665,650 | 22,344,597 (Indirect) | View |
| 2009-04-02- -2009-10-06 Purchase | 2009-10-20 9:58 pm |
AEOLUS PHARMACEUTICALS, INC. | AOLS | Xmark Opportunity Partners, LLC (10% owner) | 5,932,857 | $0.2808 | $1,665,650 | 22,344,597 (Indirect) |
View |
| 2008-10-07- -2009-03-30 Purchase(A) | 2009-04-20 4:48 pm | AEOLUS PHARMACEUTICALS, INC. | AOLS | Cavalier David (Director 10% owner) | 5,668,831 | $0.2853 | $1,617,145 | 16,316,203 (Indirect) | View |
| 2008-10-07- -2009-03-30 Purchase(A) |
2009-04-20 3:49 pm |
AEOLUS PHARMACEUTICALS, INC. | AOLS | Xmark Opportunity Partners, LLC (10% owner) | 5,668,831 | $0.2853 | $1,617,145 | 16,316,203 (Indirect) | View |
| 2009-01-31- -2009-03-30 Purchase | 2009-04-02 2:30 pm |
AEOLUS PHARMACEUTICALS, INC. | AOLS | Cavalier David (Director 10% owner) | 5,436,981 | $0.281 | $1,527,784 | 16,186,203 (Indirect) |
View |
| 2009-01-31- -2009-03-30 Purchase |
2009-04-02 2:09 pm | AEOLUS PHARMACEUTICALS, INC. | AOLS | Xmark Opportunity Partners, LLC (10% owner) | 5,436,981 | $0.281 | $1,527,784 | 16,186,203 (Indirect) |
View |
| 2005-09-07 Purchase |
2005-09-09 11:34 am | AEOLUS PHARMACEUTICALS, INC. | AOLS | XMARK ASSET MANAGEMENT LLC (10% owner) | 10,000 | $0.97 | $9,700 | 9,367,482 (Indirect) | View |
| Transaction & Date |
Reported Date | Company | Symbol | Insider Relationship | Shares Traded |
Average Price |
Total Amount | Shares Ownership | Filing |
| 2009-07-31- -2009-10-06 Other Purchase |
2009-10-21 10:54 am |
AEOLUS PHARMACEUTICALS, INC. | AOLS | Cavalier David (Director 10% owner) | 2,989,673 | $0.3504 | $1,047,556 | 25,238,733 (Indirect) |
View |
| 2009-07-31- -2009-10-06 Other Purchase | 2009-10-20 9:58 pm |
AEOLUS PHARMACEUTICALS, INC. | AOLS | Xmark Opportunity Partners, LLC (10% owner) | 2,989,673 | $0.3504 | $1,047,556 | 25,238,733 (Indirect) |
View |
| 2006-12-14 Exercise |
2006-12-18 2:07 pm |
AEOLUS PHARMACEUTICALS, INC. | AOLS | Burgoon Richard Jr (Former Chief Executive Officer) | 20,833 | $1 | $20,833 | 185,914 (Direct) |
View |
| 2006-06-06 Purchase | 2006-06-08 7:40 pm |
AEOLUS PHARMACEUTICALS, INC. | AOLS.OB | BVF PARTNERS L P BVF INC BIOTECHNOLOGY VALUE FUND L P BIOTECHNOLOGY VALUE FUND II LP BVF INVESTMENTS LLC (Indirect Beneficial Owner 10% owner) | 475,328 | $0.5 | $237,664 | 1,778,720 (Indirect) | View |
| Transaction & Date | Reported Date |
Exercisable Expiration |
Company | Symbol | Insider Relationship | Shares Traded | Conversion Price | Shares Ownership |
Filing |
| 2009-10-06 Purchase |
2009-10-21 10:54 am | N/A N/A | AEOLUS PHARMACEUTICALS, INC. | AOLS | Cavalier David (Director 10% owner) | 0 | $0.35 | 0 (Indirect) |
View |
| 2009-10-06 Other |
2009-10-21 10:54 am |
N/A 2010-11-21 |
AEOLUS PHARMACEUTICALS, INC. | AOLS | Cavalier David (Director 10% owner) | 2,150,000 | $0.28 | 0 (Indirect) |
View |
| 2009-10-06 Other | 2009-10-21 10:54 am |
N/A 2013-08-01 | AEOLUS PHARMACEUTICALS, INC. | AOLS | Cavalier David (Director 10% owner) | 1,000,000 | $0.5 | 0 (Indirect) | View |
| 2009-10-06 Other |
2009-10-21 10:54 am |
N/A 2013-09-04 | AEOLUS PHARMACEUTICALS, INC. | AOLS | Cavalier David (Director 10% owner) | 250,000 | $0.5 | 0 (Indirect) |
View |
| 2009-10-06 Other | 2009-10-21 10:54 am | N/A 2013-10-01 | AEOLUS PHARMACEUTICALS, INC. | AOLS | Cavalier David (Director 10% owner) | 250,000 | $0.5 | 0 (Indirect) |
View |
| 2009-10-06 Other | 2009-10-21 10:54 am |
N/A 2013-11-03 | AEOLUS PHARMACEUTICALS, INC. | AOLS | Cavalier David (Director 10% owner) | 250,000 | $0.5 | 0 (Indirect) | View |
| 2009-10-06 Other |
2009-10-21 10:54 am |
N/A 2013-12-01 | AEOLUS PHARMACEUTICALS, INC. | AOLS | Cavalier David (Director 10% owner) | 250,000 | $0.5 | 0 (Indirect) |
View |
| 2009-10-06 Other |
2009-10-21 10:54 am | N/A 2014-03-27 | AEOLUS PHARMACEUTICALS, INC. | AOLS | Cavalier David (Director 10% owner) | 13,392,857 | $0.35 | 0 (Indirect) | View |
| 2009-10-06 Other | 2009-10-21 10:54 am | N/A 2016-10-06 |
AEOLUS PHARMACEUTICALS, INC. | AOLS | Cavalier David (Director 10% owner) | 31,828,571 | $0.28 | 31,828,571 (Indirect) | View |
| 2009-10-06 Purchase | 2009-10-21 10:54 am | N/A 2016-10-06 | AEOLUS PHARMACEUTICALS, INC. | AOLS | Cavalier David (Director 10% owner) | 11,785,714 | $0.28 | 43,614,285 (Indirect) | View |
| 2009-10-06 Purchase | 2009-10-20 9:58 pm |
N/A N/A | AEOLUS PHARMACEUTICALS, INC. | AOLS | Xmark Opportunity Partners, LLC (10% owner) | 0 | $0.35 | 0 (Indirect) |
View |
| 2009-10-06 Other | 2009-10-20 9:58 pm |
N/A 2010-11-21 |
AEOLUS PHARMACEUTICALS, INC. | AOLS | Xmark Opportunity Partners, LLC (10% owner) | 2,150,000 | $0.28 | 0 (Indirect) | View |
| 2009-10-06 Other |
2009-10-20 9:58 pm |
N/A 2013-08-01 |
AEOLUS PHARMACEUTICALS, INC. | AOLS | Xmark Opportunity Partners, LLC (10% owner) | 1,000,000 | $0.5 | 0 (Indirect) | View |
| 2009-10-06 Other | 2009-10-20 9:58 pm | N/A 2013-09-04 | AEOLUS PHARMACEUTICALS, INC. | AOLS | Xmark Opportunity Partners, LLC (10% owner) | 250,000 | $0.5 | 0 (Indirect) | View |
| 2009-10-06 Other |
2009-10-20 9:58 pm | N/A 2013-10-01 |
AEOLUS PHARMACEUTICALS, INC. | AOLS | Xmark Opportunity Partners, LLC (10% owner) | 250,000 | $0.5 | 0 (Indirect) |
View |
| 2009-10-06 Other | 2009-10-20 9:58 pm | N/A 2013-11-03 | AEOLUS PHARMACEUTICALS, INC. | AOLS | Xmark Opportunity Partners, LLC (10% owner) | 250,000 | $0.5 | 0 (Indirect) |
View |
| 2009-10-06 Other |
2009-10-20 9:58 pm |
N/A 2013-12-01 |
AEOLUS PHARMACEUTICALS, INC. | AOLS | Xmark Opportunity Partners, LLC (10% owner) | 250,000 | $0.5 | 0 (Indirect) |
View |
| 2009-10-06 Other |
2009-10-20 9:58 pm | N/A 2014-03-27 | AEOLUS PHARMACEUTICALS, INC. | AOLS | Xmark Opportunity Partners, LLC (10% owner) | 13,392,857 | $0.35 | 0 (Indirect) | View |
| 2009-10-06 Other | 2009-10-20 9:58 pm | N/A 2016-10-06 | AEOLUS PHARMACEUTICALS, INC. | AOLS | Xmark Opportunity Partners, LLC (10% owner) | 31,828,571 | $0.28 | 31,828,571 (Indirect) | View |
| 2009-10-06 Purchase | 2009-10-20 9:58 pm | N/A 2016-10-06 | AEOLUS PHARMACEUTICALS, INC. | AOLS | Xmark Opportunity Partners, LLC (10% owner) | 11,785,714 | $0.28 | 43,614,285 (Indirect) |
View |
| 2009-07-30 Option Award |
2009-07-30 6:00 pm | N/A 2019-07-30 | AEOLUS PHARMACEUTICALS, INC. | AOLS | Suzdak Peter David (Director) | 11,250 | $0.39 | 11,250 (Direct) |
View |
| 2009-07-30 Option Award | 2009-07-30 5:56 pm |
N/A 2019-07-30 | AEOLUS PHARMACEUTICALS, INC. | AOLS | Lewis Michael E (Director) | 11,250 | $0.39 | 11,250 (Direct) |
View |
| 2009-07-30 Option Award | 2009-07-30 5:51 pm |
N/A 2019-07-30 |
AEOLUS PHARMACEUTICALS, INC. | AOLS | Krivulka Joseph J (Director) | 11,250 | $0.39 | 11,250 (Direct) | View |
| 2009-07-30 Option Award | 2009-07-30 5:46 pm |
N/A 2019-07-30 | AEOLUS PHARMACEUTICALS, INC. | AOLS | Farah John M JR (Director) | 11,250 | $0.39 | 11,250 (Direct) | View |
| 2009-04-30 Option Award | 2009-07-30 5:42 pm | N/A 2019-04-30 |
AEOLUS PHARMACEUTICALS, INC. | AOLS | RALLIS CHRIS A (Director) | 3,750 | $0.38 | 3,750 (Direct) | View |
| 2009-07-30 Option Award |
2009-07-30 5:42 pm | N/A 2019-07-30 | AEOLUS PHARMACEUTICALS, INC. | AOLS | RALLIS CHRIS A (Director) | 15,000 | $0.39 | 15,000 (Direct) |
View |
| 2009-04-30 Option Award |
2009-07-30 5:34 pm |
N/A 2019-04-30 |
AEOLUS PHARMACEUTICALS, INC. | AOLS | KUMAR AMIT (Director) | 3,750 | $0.38 | 3,750 (Direct) | View |
| 2009-07-30 Option Award |
2009-07-30 5:34 pm | N/A 2019-07-30 |
AEOLUS PHARMACEUTICALS, INC. | AOLS | KUMAR AMIT (Director) | 15,000 | $0.39 | 15,000 (Direct) | View |
| 2009-07-30 Option Award | 2009-07-30 5:26 pm |
N/A 2019-07-30 | AEOLUS PHARMACEUTICALS, INC. | AOLS | Cavalier David (Director 10% owner) | 15,000 | $0.39 | 15,000 (Direct) |
View |
| 2009-04-30 Option Award |
2009-07-30 5:26 pm | N/A 2019-04-30 | AEOLUS PHARMACEUTICALS, INC. | AOLS | Cavalier David (Director 10% owner) | 3,750 | $0.38 | 3,750 (Direct) |
View |
| 2009-07-30 Option Award |
2009-07-30 5:16 pm | N/A 2019-07-30 |
AEOLUS PHARMACEUTICALS, INC. | AOLS | McManus John L (Chief Executive Officer) | 250,000 | $0.39 | 250,000 (Direct) |
View |
| 2009-07-10 Option Award |
2009-07-30 4:31 pm |
N/A 2019-07-10 |
AEOLUS PHARMACEUTICALS, INC. | AOLS | MCMANUS MICHAEL P (Chief Financial Officer) | 90,000 | $0.39 | 90,000 (Direct) |
View |
| 2009-06-04 Option Award |
2009-06-05 2:39 pm | N/A 2019-06-04 | AEOLUS PHARMACEUTICALS, INC. | AOLS | Cavalier David (Director 10% owner) | 11,250 | $0.35 | 11,250 (Direct) | View |
| 2009-06-04 Option Award |
2009-06-05 2:29 pm |
N/A 2019-06-04 | AEOLUS PHARMACEUTICALS, INC. | AOLS | Farah John M JR (Director) | 11,250 | $0.35 | 11,250 (Direct) |
View |
| 2009-06-04 Option Award |
2009-06-05 2:15 pm |
N/A 2019-06-04 | AEOLUS PHARMACEUTICALS, INC. | AOLS | Suzdak Peter David (Director) | 11,250 | $0.35 | 11,250 (Direct) | View |
| 2009-06-04 Option Award | 2009-06-05 2:09 pm |
N/A 2019-06-04 | AEOLUS PHARMACEUTICALS, INC. | AOLS | RALLIS CHRIS A (Director) | 11,250 | $0.35 | 11,250 (Direct) | View |
| 2009-06-04 Option Award | 2009-06-05 2:03 pm | N/A 2019-06-04 | AEOLUS PHARMACEUTICALS, INC. | AOLS | Lewis Michael E (Director) | 11,250 | $0.35 | 11,250 (Direct) |
View |
| 2009-06-04 Option Award |
2009-06-05 1:52 pm | N/A 2019-06-04 |
AEOLUS PHARMACEUTICALS, INC. | AOLS | KUMAR AMIT (Director) | 11,250 | $0.35 | 11,250 (Direct) | View |
| 2009-05-06 Option Award | 2009-05-07 6:47 pm | N/A 2019-05-06 | AEOLUS PHARMACEUTICALS, INC. | AOLS | MCMANUS JOHN L (President & CEO) | 1,000,000 | $0.3 | 1,000,000 (Direct) |
View |
| 2009-03-30 Purchase | 2009-04-02 2:30 pm |
N/A 2014-03-30 |
AEOLUS PHARMACEUTICALS, INC. | AOLS | Cavalier David (Director 10% owner) | 13,392,857 | $0.35 | 13,392,857 (Indirect) | View |
| 2009-03-30 Purchase | 2009-04-02 2:09 pm | N/A 2014-03-30 |
AEOLUS PHARMACEUTICALS, INC. | AOLS | Xmark Opportunity Partners, LLC (10% owner) | 13,392,857 | $0.35 | 13,392,857 (Indirect) |
View |
| 2009-03-26 Option Award |
2009-03-27 6:17 pm | N/A 2019-03-26 |
AEOLUS PHARMACEUTICALS, INC. | AOLS | Suzdak Peter David (Director) | 11,250 | $0.33 | 11,250 (Direct) |
View |
| 2009-03-26 Option Award |
2009-03-27 6:11 pm |
N/A 2019-03-26 | AEOLUS PHARMACEUTICALS, INC. | AOLS | RALLIS CHRIS A (Director) | 11,250 | $0.33 | 11,250 (Direct) | View |
| 2007-07-31 Option Award |
2007-08-01 2:27 pm |
2007-07-31 2017-07-31 |
AEOLUS PHARMACEUTICALS, INC. | AOLS | ALEXANDER ELAINE (EVP & Chief Medical Officer) | 2,000 | $0.72 | 2,000 (Direct) |
View |
| 2006-12-14 Exercise | 2006-12-18 2:07 pm | 2005-07-12 2015-07-12 |
AEOLUS PHARMACEUTICALS, INC. | AOLS | Burgoon Richard Jr (Former Chief Executive Officer) | 20,833 | $1 | 83,336 (Direct) | View |
| 2006-06-06 Purchase |
2006-06-08 7:40 pm |
N/A N/A |
AEOLUS PHARMACEUTICALS, INC. | AOLS.OB | BVF PARTNERS L P BVF INC BIOTECHNOLOGY VALUE FUND L P BIOTECHNOLOGY VALUE FUND II LP BVF INVESTMENTS LLC (Indirect Beneficial Owner 10% owner) | 37,000 | $0.5 | 623,496 (Indirect) | View |
| 2006-06-06 Purchase | 2006-06-08 7:40 pm |
N/A N/A |
AEOLUS PHARMACEUTICALS, INC. | AOLS.OB | BVF PARTNERS L P BVF INC BIOTECHNOLOGY VALUE FUND L P BIOTECHNOLOGY VALUE FUND II LP BVF INVESTMENTS LLC (Indirect Beneficial Owner 10% owner) | 24,000 | $0.5 | 599,496 (Indirect) | View |
| 2006-06-06 Purchase | 2006-06-08 7:40 pm | N/A N/A | AEOLUS PHARMACEUTICALS, INC. | AOLS.OB | BVF PARTNERS L P BVF INC BIOTECHNOLOGY VALUE FUND L P BIOTECHNOLOGY VALUE FUND II LP BVF INVESTMENTS LLC (Indirect Beneficial Owner 10% owner) | 57,832 | $0.5 | 541,664 (Indirect) |
View |
| 2006-03-31 Option Award |
2006-04-04 12:57 pm |
2006-03-31 2016-03-31 |
AEOLUS PHARMACEUTICALS, INC. | AOLS | MCMANUS MICHAEL P (Chief Accounting Officer) | 1,250 | $0.8 | 1,250 (Direct) |
View |
|
© 2005-2009 SecForm4.Com All rights reserved. Archives: 2009 2008 2007 2006 2005 2004 ... Sat, 21 Nov 2009 10:13:33 -0600 |
SEC is the U.S. Securities and Exchange Commission. EDGAR is a trademark of the SEC. SecForm4.Com is not affiliated with or approved by the U.S. Securities and Exchange Commission (SEC). Terms of Use | Privacy Statement | |